Pediatric multifocal glioblastoma multiforme with fulminant course

ABSTRACT

Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor. GBM in children is less common than in adults and has a better prognosis. Pediatric GBM is a rare entity, and a multifocal development in a pediatric GBM is much rarer. We report to you one such rare case of pediatric multifocal GBM in a 5-year-old child who developed rapidly increasing multiple lesions after radiotherapy. More studies are required to study the genetic analysis, tumor behavior, management and outcome of these rare tumors.

Key words

Multifocal GBM - multicentric GBM - pediatric GBM - recraniotomy

• References

• 1 Perkins SM, Rubin JB, Leonard JR, Smyth MD, El Naqa I, Michalski JM. et al Glioblastoma in Children: A Single-Institution Experience. Int J Radiat Oncol Biol Phys 2011; 80: 1117-21
• 2 Song KS, Phi JH, Cho BK, Wang KC, Lee JY, Kim DG. et al Long-term outcomes in children with glioblastoma. J Neurosurg Pediatr 2010; 6: 145-9
• 3 Lamborn KR, Chang SM, Prados MD. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol 2004; 6: 227-35
• 4 Rao KC, Levine H, Itani A, Sajor E, Robinson W. CT findings in multicentric glioblastoma: diagnostic-pathologic correlation. J Comput Tomogr 1980; 4: 187-92
• 5 Prather JL, Long JM, van Heertum R, Hardman J. Multicentric and isolated multifocal glioblastoma multiforme simulating metastatic disease. Br J Radiol 1975; 48: 10-5
• 6 Showalter TN, Andrel J, Andrews DW, Curran Jr WJ, Daskalakis C, Werner-Wasik M. Multifocal glioblastoma multiforme: Prognostic factors and patterns of progression. Int J Radiat Oncol Biol Phys 2007; 69: 820-4
• 7 Krex D, Mohr B, Appelt H, Schackert HK, Schackert G. Genetic analysis of a multifocal glioblastoma multiforme: A suitable tool to gain new aspects in glioma development. Neurosurg 2003; 53: 1377-84 discussion 1384
• 8 Batzdorf U, Malamud N. The problem of multicentric gliomas. J Neurosurg 1963; 20: 122-36
• 9 Pollack IF, Hamilton RL, Burnham J, Holmes EJ, Finkelstein SD, Sposto R. et al Impact of proliferation index on outcome in childhood malignant gliomas: Results in a multi-institution-al cohort. Neurosurg 2002; 50: 1238-45
• 10 Hirschfeld S, Shapiro A, Dagher R, Pazdur R. Pediatric Oncology: Regulatory Initiatives. Oncologist 2000; 5: 441-4
• 11 Bethesdatrials.cancer.gov. National Cancer Institute. [Last updated 2001 Jan 01; cited 2011 Nov 29] Available from http://bethesdatrials.cancer.gov/pediatric/index.aspx
• 12 Weitman S, Ochoa S, Sullivan J, Shuster J, Winick N, Pratt C. et al Pediatric phase II cancer chemotherapy trials: A Pediatric Oncology Group study. J Pediatr Hematol Oncol 1997; 19: 187-91
• 13 Nguyen TD, Lassman AB, Lis E, Rosen N, Shaffer DR, Scher HI. et al A pilot study to assess the tolerability and efficacy of RAD-001 (everolimus) with gefitinib in patients with recurrent glioblastoma multiforme. Neuro-Oncology 2006; 8: 447